Breaking News Instant updates and real-time market news.

NFLX

Netflix

$346.40

13.29 (3.99%)

09:28
10/17/18
10/17
09:28
10/17/18
09:28

Netflix price target raised to $440 from $400 at BMO Capital

BMO Capital analyst Daniel Salmon raised his price target on Netflix to $440 and kept his Outperform rating after its "strong" Q3 earnings beat and positive Q4 guidance, saying the company's subscriber growth trajectory is "back on track" after disappointing Q2. The analyst cites increasing performance of its non-English original content, more efficient marketing, and "continued contribution of distribution partnerships". Salmon also contends that Netflix is still the "clear leader in the streaming universe" with added incremental benefits coming from its small but steady licensing revenue growth.

  • 13

    Nov

NFLX Netflix
$346.40

13.29 (3.99%)

10/17/18
BERN
10/17/18
NO CHANGE
BERN
Pace of Netflix subscriber growth 'astounding,' says Bernstein
Bernstein analyst Todd Juenger says that while Netflix's rare subscriber miss last quarter caused investors to question whether it as just a blip or an early warning of deceleration, this quarter's blow out result seems to put that debate to rest. The pace of Netflix subscriber growth is "astounding," he contends. The analyst notes that it took 10 years to go from 0 to 100M paid subscriptions, but he projects it will take only 2 years to go from 100M to 150M.
10/17/18
IMPC
10/17/18
NO CHANGE
Target $464
IMPC
Outperform
Netflix price target lowered to $464 from $494 at Imperial Capital
Imperial Capital analyst David Miller lowered his price target for Netflix to $464 while keeping an Outperform rating on the shares following last night's Q3 results. The Q4 guidance is "slightly light on most metrics," Miller tells investors in a post-earnings research note. He notes his new price target still implies 34% upside.
10/17/18
LOOP
10/17/18
NO CHANGE
Target $385
LOOP
Hold
Netflix price target raised to $385 from $365 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Netflix (NFLX) to $385 from $365 after its reported strong subscription adds in Q3 and expectations of more adds in Q4. The analyst also points to the management's FY19 operating margin target of 13% - up from 10%-11% target for FY18 - and expectations of "peak" negative free cash flows in the next two years. Gould also keeps his Hold rating on Netflix given the ongoing risks around competition from Amazon (AMZN) and other content providers along with a strong USD weighing on international sales.
10/17/18
WEDB
10/17/18
NO CHANGE
Target $150
WEDB
Underperform
Netflix price target raised to $150 from $125 at Wedbush
Wedbush analyst Michael Pachter raised his price target for Netflix to $150 from $125 following quarterly results. The analyst expects content acquisition spending to trigger substantial cash burn for many years. Notwithstanding three Netflix price increases in the last five years, cash burn continues to grow, he notes. Further, the analyst says international profits may remain elusive due to competition for content and subscriptions, and last year's price increases could cause a deceleration in subscriber growth. He reiterates an Underperform rating on the shares.

TODAY'S FREE FLY STORIES

ADS

Alliance Data

$199.76

-5.49 (-2.67%)

07:30
11/15/18
11/15
07:30
11/15/18
07:30
Hot Stocks
Alliance Data reports October net charge offs 5.7% vs. 5.9% last month »

Reports October…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KBH

KB Home

$20.80

-0.135 (-0.64%)

07:30
11/15/18
11/15
07:30
11/15/18
07:30
Hot Stocks
KB Home lowers FY18 housing revenue view to $4.5B from $4.6B »

Sees Q4: housing revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$34.23

-1.53 (-4.28%)

07:28
11/15/18
11/15
07:28
11/15/18
07:28
Upgrade
Mylan rating change  »

Mylan upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$73.26

-1.38 (-1.85%)

07:28
11/15/18
11/15
07:28
11/15/18
07:28
Initiation
Jacobs Engineering initiated  »

Jacobs Engineering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

URI

United Rentals

$119.67

(0.00%)

07:27
11/15/18
11/15
07:27
11/15/18
07:27
Recommendations
United Rentals analyst commentary  »

United Rentals on a path…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$73.26

-1.38 (-1.85%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Initiation
Jacobs Engineering initiated  »

Jacobs Engineering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

AAPL

Apple

$186.81

-5.42 (-2.82%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Recommendations
Apple analyst commentary  »

Apple dip a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMIH

NMI Holdings

$20.16

-0.54 (-2.61%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
NMI Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

WMS

Advanced Drainage

$26.77

0.28 (1.06%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
Advanced Drainage to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UFI

Unifi

$27.00

-0.03 (-0.11%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
Unifi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

WFC

Wells Fargo

$52.15

-0.59 (-1.12%)

, USB

U.S. Bancorp

$54.01

0.32 (0.60%)

07:23
11/15/18
11/15
07:23
11/15/18
07:23
Periodicals
Senator Warren questions regulators on leveraged lending, Reuters reports »

U.S. Senator Elizabeth…

WFC

Wells Fargo

$52.15

-0.59 (-1.12%)

USB

U.S. Bancorp

$54.01

0.32 (0.60%)

BAC

Bank of America

$27.23

-0.53 (-1.91%)

JPM

JPMorgan

$107.36

-2.23 (-2.03%)

GS

Goldman Sachs

$202.43

-2.49 (-1.22%)

MS

Morgan Stanley

$43.85

-0.81 (-1.81%)

C

Citi

$63.50

-1.28 (-1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 14

    Jan

  • 12

    Feb

  • 26

    Feb

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

CYTX

Cytori Therapeutics

$0.34

-0.0064 (-1.87%)

07:21
11/15/18
11/15
07:21
11/15/18
07:21
Recommendations
Cytori Therapeutics analyst commentary  »

Cytori Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$157.15

-1 (-0.63%)

07:20
11/15/18
11/15
07:20
11/15/18
07:20
Conference/Events
Air Products management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PCG

PG&E

$25.66

-7.04 (-21.53%)

07:19
11/15/18
11/15
07:19
11/15/18
07:19
Downgrade
PG&E rating change  »

PG&E downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.55

0.01 (0.10%)

, VLKAY

Volkswagen

$0.00

(0.00%)

07:18
11/15/18
11/15
07:18
11/15/18
07:18
Periodicals
Ford CEO open to autonomous vehicles investors but cautious on VW, Reuters says »

Ford Motor (F) CEO Jim…

F

Ford

$9.55

0.01 (0.10%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

KBH

KB Home

$20.80

-0.135 (-0.64%)

07:17
11/15/18
11/15
07:17
11/15/18
07:17
Recommendations
KB Home analyst commentary  »

KB Home price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRO

Frontline

$5.93

-0.1 (-1.66%)

07:17
11/15/18
11/15
07:17
11/15/18
07:17
Upgrade
Frontline rating change  »

Frontline upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPTN

SpartanNash

$16.99

-0.44 (-2.52%)

07:17
11/15/18
11/15
07:17
11/15/18
07:17
Upgrade
SpartanNash rating change  »

SpartanNash upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HGV

Hilton Grand Vacations

$28.27

0.48 (1.73%)

07:16
11/15/18
11/15
07:16
11/15/18
07:16
Upgrade
Hilton Grand Vacations rating change  »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

OAS

Oasis Petroleum

$8.28

-0.04 (-0.48%)

07:16
11/15/18
11/15
07:16
11/15/18
07:16
Upgrade
Oasis Petroleum rating change  »

Oasis Petroleum upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

CNST

Constellation Pharmaceuticals

$5.83

0.025 (0.43%)

07:16
11/15/18
11/15
07:16
11/15/18
07:16
Hot Stocks
Constellation Pharmaceuticals to present data on EZH2 program at conference »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

APRN

Blue Apron

$1.17

-0.055 (-4.51%)

07:15
11/15/18
11/15
07:15
11/15/18
07:15
Recommendations
Blue Apron analyst commentary  »

Blue Apron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

BECN

Beacon Roofing

$28.07

0.81 (2.97%)

07:14
11/15/18
11/15
07:14
11/15/18
07:14
Recommendations
Beacon Roofing analyst commentary  »

Beacon Roofing price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 13

    Dec

WEX

Wex

$157.62

-4.01 (-2.48%)

07:14
11/15/18
11/15
07:14
11/15/18
07:14
Recommendations
Wex analyst commentary  »

JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.